Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Guidance on contraception for women aged over 40 years.
Al-Hassan N. Al-Hassan N. J Fam Plann Reprod Health Care. 2011 Apr;37(2):124-5; discussion 125. doi: 10.1136/jfprhc.2011.0065. J Fam Plann Reprod Health Care. 2011. PMID: 21454281 Free article. No abstract available.
Menstrual migraine.
Al-Hassan N. Al-Hassan N. J Fam Plann Reprod Health Care. 2007 Oct;33(4):289; author reply 289. doi: 10.1783/147118907782101959. J Fam Plann Reprod Health Care. 2007. PMID: 17925127 Free article. No abstract available.
Emergency contraception and liver enzyme-inducing drugs.
Al-Hassan N. Al-Hassan N. J Fam Plann Reprod Health Care. 2006 Jan;32(1):52; author reply 52-3. doi: 10.1783/147118906775275406. J Fam Plann Reprod Health Care. 2006. PMID: 16492345 Free article. No abstract available.
Green synthesized silver nanoparticles using the plant-based reducing agent Matricaria chamomilla induce cell death in colorectal cancer cells.
Abdellatif AAH, Mohammed HA, Abdulla MH, Alsubaiyel AM, Mahmood A, Samman WA, Alhaddad AA, Al Rugaie O, Alsharidah M, Vaali-Mohammed MA, Al Hassan N, Taha HH. Abdellatif AAH, et al. Among authors: al hassan n. Eur Rev Med Pharmacol Sci. 2023 Oct;27(20):10112-10125. doi: 10.26355/eurrev_202310_34191. Eur Rev Med Pharmacol Sci. 2023. PMID: 37916381 Free article.
Pembrolizumab for the Treatment of Relapsed and Refractory Classical Hodgkin Lymphoma After Autologous Transplant and in Transplant-Naïve Patients.
Halahleh K, Al Sawajneh S, Saleh Y, Shahin O, Abufara A, Ma'koseh M, Abdel-Razeq R, Barakat F, Abdelkhaleq H, Al-Hassan N, Atiyyat R, Al-Faker N, Omari Z, Ghatasheh H, Jaradat I, Muradi I, Iyad S, Bazarbachi A. Halahleh K, et al. Among authors: al hassan n. Clin Lymphoma Myeloma Leuk. 2022 Aug;22(8):589-595. doi: 10.1016/j.clml.2022.02.009. Epub 2022 Mar 4. Clin Lymphoma Myeloma Leuk. 2022. PMID: 35490153
22 results